ATLANTA, GA – – (Globe Newswire – February 11, 2025) – – A securities class action lawsuit has been filed against (“Neumora” or the “Company”) (NASDAQ: NMRA) on behalf of a class of all persons or entities who purchased or otherwise acquired Neumora common stock pursuant and/or traceable to its September 15, 2023 initial public offering (the “IPO”), and who were damaged thereby. The lawsuit alleges that certain documents issued in connection with the IPO were inaccurate and misleading, contained inaccurate and misleading statements of material facts, omitted to state material facts necessary to render the statements therein not misleading, and omitted to state material facts required to be stated therein.

If you bought shares of Neumora pursuant and/or traceable to the IPO and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/neumora-therapeutics/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is April 7, 2025.